↓ Skip to main content

Cochrane Database of Systematic Reviews

Edaravone for acute ischaemic stroke

Overview of attention for article published in Cochrane database of systematic reviews, December 2011
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (79th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
9 tweeters

Citations

dimensions_citation
76 Dimensions

Readers on

mendeley
73 Mendeley
Title
Edaravone for acute ischaemic stroke
Published in
Cochrane database of systematic reviews, December 2011
DOI 10.1002/14651858.cd007230.pub2
Pubmed ID
Authors

Shejun Feng, Qingwei Yang, Ming Liu, Weizheng Li, Wenming Yuan, Shihong Zhang, Bo Wu, Juntao Li

Abstract

Neuroprotection is a promising therapeutic strategy for the treatment of acute ischaemic stroke. Edaravone is a neuroprotective agent that has been widely used in China, and several studies have suggested that it may be beneficial in acute ischaemic stroke.

Twitter Demographics

The data shown below were collected from the profiles of 9 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 73 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Japan 1 1%
Unknown 72 99%

Demographic breakdown

Readers by professional status Count As %
Student > Master 13 18%
Student > Ph. D. Student 9 12%
Researcher 9 12%
Student > Bachelor 6 8%
Student > Postgraduate 4 5%
Other 18 25%
Unknown 14 19%
Readers by discipline Count As %
Medicine and Dentistry 30 41%
Nursing and Health Professions 5 7%
Pharmacology, Toxicology and Pharmaceutical Science 4 5%
Neuroscience 4 5%
Computer Science 3 4%
Other 11 15%
Unknown 16 22%

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 December 2016.
All research outputs
#3,452,630
of 14,613,233 outputs
Outputs from Cochrane database of systematic reviews
#6,110
of 11,030 outputs
Outputs of similar age
#42,765
of 212,842 outputs
Outputs of similar age from Cochrane database of systematic reviews
#265
of 497 outputs
Altmetric has tracked 14,613,233 research outputs across all sources so far. Compared to these this one has done well and is in the 76th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,030 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 22.5. This one is in the 44th percentile – i.e., 44% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 212,842 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 79% of its contemporaries.
We're also able to compare this research output to 497 others from the same source and published within six weeks on either side of this one. This one is in the 46th percentile – i.e., 46% of its contemporaries scored the same or lower than it.